Resumes
Resumes
Diane Tribble Phones & Addresses
-
Bloomsbury, NJ
-
Wading River, NY
-
Julian, CA
-
Stewartsville, NJ
-
Asbury, NJ
-
Carlsbad, CA
-
Mountainside, NJ
-
Sunnyvale, CA
-
Redwood City, CA
-
Berkeley, CA
-
Westfield, NJ
Work
Company:
Isis pharmaceuticals inc
Address:
2292 Faraday Ave, Carlsbad, CA 92008
Phones:
(760) 931-9200
Position:
Manager
Industries:
Commercial Physical and Biological Research
Business Records
Name / Title
Company / Classification
Phones & Addresses
Manager
Isis Pharmaceuticals Inc
Commercial Physical and Biological Research
Commercial Physical and Biological Research
2292 Faraday Ave, Carlsbad, CA 92008
Manager
Isis Pharmaceuticals Inc
Commercial Physical and Biological Research
Commercial Physical and Biological Research
2292 Faraday Ave, Carlsbad, CA 92008
Publications
Us Patents
Administering Antisense Oligonucleotides Complementary To Human Apolipoprotein B
View pageUS Patent:
20170096662, Apr 6, 2017
Filed:
May 18, 2016
Appl. No.:
15/157678
Inventors:
- Chicago IL, US
Zhengrong Yu - Carlsbad CA, US
Mark K. Wedel - Temecula CA, US
Diane Tribble - Asbury NJ, US
Zhengrong Yu - Carlsbad CA, US
Mark K. Wedel - Temecula CA, US
Diane Tribble - Asbury NJ, US
Assignee:
Kastle Therapeutics, LLC - Chicago IL
International Classification:
C12N 15/113
Abstract:
Methods for long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated ApoB are provided.
Methods For Treating Hypercholesterolemia
View pageUS Patent:
20150167005, Jun 18, 2015
Filed:
Nov 12, 2014
Appl. No.:
14/539831
Inventors:
- CARLSBAD CA, US
Rosanne M. Crooke - Carlsbad CA, US
Mark J. Graham - San Clemente CA, US
Kristina M. Lemonidis - Oceanside CA, US
Sanjay Bhanot - Carlsbad CA, US
Diane Tribble - Asbury NJ, US
Andrew T. Watt - San Diego CA, US
Rosanne M. Crooke - Carlsbad CA, US
Mark J. Graham - San Clemente CA, US
Kristina M. Lemonidis - Oceanside CA, US
Sanjay Bhanot - Carlsbad CA, US
Diane Tribble - Asbury NJ, US
Andrew T. Watt - San Diego CA, US
Assignee:
ISIS PHARMACEUTICALS, INC. - CARLSBAD CA
International Classification:
C12N 15/113
Abstract:
Disclosed herein are antisense compounds and methods for decreasing LDL-C in an individual having elevated LDL-C. Additionally disclosed are antisense compounds and methods for treating, preventing, or ameliorating hypercholesterolemia and/or atherosclerosis. Further disclosed are antisense compounds and methods for decreasing coronary heart disease risk. Such methods include administering to an individual in need of treatment an antisense compound targeted to a PCSK9 nucleic acid. The antisense compounds administered include gapmer antisense oligonucleotides.
Methods For Treating Hypercholesterolemia
View pageUS Patent:
20140194492, Jul 10, 2014
Filed:
Jan 10, 2014
Appl. No.:
14/152825
Inventors:
- Carlsbad CA, US
Rosanne M. Crooke - Carlsbad CA, US
Mark J. Graham - San Clemente CA, US
Kristina M. Lemonidis - Oceanside CA, US
Sanjay Bhanot - Carlsbad CA, US
Diane Tribble - Asbury NJ, US
Andrew T. Watt - San Diego CA, US
Rosanne M. Crooke - Carlsbad CA, US
Mark J. Graham - San Clemente CA, US
Kristina M. Lemonidis - Oceanside CA, US
Sanjay Bhanot - Carlsbad CA, US
Diane Tribble - Asbury NJ, US
Andrew T. Watt - San Diego CA, US
Assignee:
ISIS PHARMACEUTICALS, INC. - Carlsbad CA
International Classification:
C12N 15/113
US Classification:
514 44 A, 536 245
Abstract:
Disclosed herein are antisense compounds and methods for decreasing LDL-C in an individual having elevated LDL-C. Additionally disclosed are antisense compounds and methods for treating, preventing, or ameliorating hypercholesterolemia and/or atherosclerosis. Further disclosed are antisense compounds and methods for decreasing coronary heart disease risk. Such methods include administering to an individual in need of treatment an antisense compound targeted to a PCSK9 nucleic acid. The antisense compounds administered include gapmer antisense oligonucleotides.